President Donald Trump said all 50 states will participate in the Medicaid GENEROUS model, which would provide Most Favored Nation pricing by lowering the net cost of selected drugs toward prices paid in certain other countries. The administration says Medicaid could save billions, while the White House estimated in May that related pharmaceutical agreements could save $529 billion over 10 years. Documents shared with The Washington Post indicate the confidential deals also include inducements for drugmakers to raise prices overseas and protection from President Donald Trump's tariffs. Experts say the savings and durability of the arrangements cannot be assessed independently because key terms remain undisclosed.